InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
5
已披露卖出
3
T+90 胜率
25%
T+90 平均收益
-15.5%
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Chang Carmen, 董事. Insider active across 13 companies, notably Monte Rosa Therapeutics, Inc.. Aggregated, 22 filings have been published. Breakdown: 5 buys · 3 sells. Total volume traded: €8.5m. Activity tracked since 1 November 2021. The latest transaction was filed on 10 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chang Carmen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
34,260 股Common StockSEC:0001193125-26-271323:0
207,100 股@ US$11.1167.8% 占其流量Common StockSEC:0001193125-26-104717:0
标准退出：2026年6月8日 (T+90)
1,619,240 股Common StockSEC:0001193125-26-046663:0
189,195 股@ US$0.01100.0% 占其流量Common StockSEC:0001193125-25-232142:0
21,765 股0Common StockSEC:0000950170-25-077140:0
1,023,103 股Common StockSEC:0000950170-24-107552:0
18,669 股0Common StockSEC:0000950170-24-064775:0
17,857 股@ US$56.00100.0% 占其流量Common StockSEC:0000950170-24-047687:0
标准退出：2024年7月21日 (T+90)
333,333 股@ US$3.00100.0% 占其流量Common StockSEC:0001209191-23-042799:0
标准退出：2023年10月15日 (T+90)
2,000,000 股0Common StockSEC:0001209191-23-037356:0
16,186 股0Common StockSEC:0001209191-23-032646:0
1,226 股@ US$11.8243100.0% 占其流量Common StockSEC:0001209191-23-019642:0
1,226 股0Common StockSEC:0001209191-23-010893:0
4,294,207 股Common StockSEC:0001209191-22-059450:0
5,931,843 股@ €0.0609100.0% 占其流量Common StockSEC:0001209191-22-032322:0
8,655 股0Common StockSEC:0001209191-22-029409:0
2,631,578 股@ US$1.90100.0% 占其流量Common StockSEC:0001209191-22-024315:0
标准退出：2022年7月10日 (T+90)
37,570 股@ US$1.321100.0% 占其流量Common StockSEC:0001209191-21-071268:0
22,985 股0Common StockSEC:0001209191-21-062867:0
1,851,852 股Common StockSEC:0001209191-21-061093:0
标准退出：2022年1月16日 (T+90)
2,715,968 股Common StockSEC:0001209191-21-044039:0
5,864,718 股Common StockSEC:0001209191-21-044190:0
22 条申报中的 22 条
About Chang Carmen
Chang Carmen is Administrateur and has 22 filings in total. Across the 22 sampled filings between 2021-06-30 and 2026-06-15, the reported amounts are EUR 8405496 of buys and EUR 57460 of sells, with Attribution as the modal transaction nature. The largest filings involve Trevi Therapeutics, Inc., Korro Bio, Inc., Savara Inc, Metacrine, Inc. and Coursera, Inc.
